Cargando…
A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4
Malignant brain tumors, known as H3K27-altered diffuse midline glioma (DMG) and H3G34-mutant diffuse hemispheric glioma (DHG), can affect individuals of all ages and are classified as CNS WHO grade 4. We comprehensively characterized 390 H3F3A-mutant diffuse gliomas (201 females, 189 males) arising...
Autores principales: | Williams, Erik A., Brastianos, Priscilla K., Wakimoto, Hiroaki, Zolal, Amir, Filbin, Mariella G., Cahill, Daniel P., Santagata, Sandro, Juratli, Tareq A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412483/ https://www.ncbi.nlm.nih.gov/pubmed/37524847 http://dx.doi.org/10.1007/s00401-023-02609-6 |
Ejemplares similares
-
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
por: Williams, Erik A., et al.
Publicado: (2020) -
HGG-25. TARGETED DRUGS SYNERGIZE WITH DOUBLE ALKYLATOR THERAPY IN H3.3 G34R/V PEDIATRIC HIGH-GRADE GLIOMA
por: Haase, Rebecca, et al.
Publicado: (2023) -
High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020) -
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
por: Juratli, Tareq A., et al.
Publicado: (2017) -
In Reply: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas
por: Fujio, Shingo, et al.
Publicado: (2019)